Share

Addiction Audio

The podcast from the journal Addiction

Welcome to the podcast from the journal Addiction. Usually (but not always) hosted by Suzi Gage, the Social Media editor for the journal, the podcast includes interviews with Addiction authors about their work, details a
Latest Episode10/27/2021

JITAIs and using smartphones to prevent lapse with Olga Perskie

Ep. 36
Rob Calder talks to Dr Olga Perski about her recent research on just-in-time adaptive interventions (JITAIs) whereby smartphones are used to help prevent lapses among people who are trying to quit or reduce alcohol, tobacco or other drug use. Dr Perski talks about why the literature is so complex and how defining JITAIs is difficult in the first place. She talks about the potential for Ecological Momentary Assessment (EMA), GPS positioning and micro-randomised trial studies to contribute in this area, and how we may not want to press ahead with full-scale RCTs before having conducted additional conceptual and computational work to clarify what JITAIs are and how to develop them. Dr Perski also discusses the challenges of regulating mobile health apps so that people can access apps based on evidence of effectiveness. This episode was recorded online on 30 September 2021.Perski, O., Hébert, E.T., Naughton, F., Hekler, E.B., Brown, J. and Businelle, M.S. Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: A systematic review.Addiction 2021; doi:10.1111/add.15687
10/27/2021

JITAIs and using smartphones to prevent lapse with Olga Perskie

Ep. 36
Rob Calder talks to Dr Olga Perski about her recent research on just-in-time adaptive interventions (JITAIs) whereby smartphones are used to help prevent lapses among people who are trying to quit or reduce alcohol, tobacco or other drug use. Dr Perski talks about why the literature is so complex and how defining JITAIs is difficult in the first place. She talks about the potential for Ecological Momentary Assessment (EMA), GPS positioning and micro-randomised trial studies to contribute in this area, and how we may not want to press ahead with full-scale RCTs before having conducted additional conceptual and computational work to clarify what JITAIs are and how to develop them. Dr Perski also discusses the challenges of regulating mobile health apps so that people can access apps based on evidence of effectiveness. This episode was recorded online on 30 September 2021.Perski, O., Hébert, E.T., Naughton, F., Hekler, E.B., Brown, J. and Businelle, M.S. Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: A systematic review.Addiction 2021; doi:10.1111/add.15687
10/20/2021

Mental imagery and cocaine craving with John Marsden

Ep. 35
Rob Calder talks to Professor John Marsden about cocaine cravings. Professor Marsden discusses the lack of pharmacological treatments for cocaine, and about his recent study using mental imagery to address cocaine cravings. He talks about the benefits of positive imagery compared with negative imagery. He then discusses how useful mixed-methods research can be and the importance of writing up data from unfinished trials.Lowry, N., Marsden, J., Clydesdale, B., Eastwood, B., Havelka, E.M. and Goetz, C. Acute impact of self‐guided mental imagery on craving in cocaine use disorder: a mixed‐methods analysis of a randomized controlled trial.Addiction 2021; doi:10.1111/add.15405https://onlinelibrary.wiley.com/doi/full/10.1111/add.15405
10/15/2021

Drug treatment commissioning and market mechanisms with Alison Ritter

Ep. 34
Professor Alison Ritter talks about her recent paper “Are market mechanisms associated with alcohol and other drug treatment outcomes” and about the Australian context of drug treatment provision and commissioning. We discuss the challenges of measuring outcomes against commissioning structures and Professor Ritter explains how funding arrangements can end up looking like a bowl of spaghetti. Alison discusses why governments don’t necessarily have to tender competitively, about the burdens associated with the machinery of recommissioning and about the potential for fixed-price tendering to improve the quality of addiction treatment services.Ritter, A., van de Ven, K., Vuong, T., Chalmers, J., Dobbins, T., Livingston, M. and Berends, L. Are market mechanisms associated with alcohol and other drug treatment outcomes?.Addiction 2021; doi:10.1111/add.15681 https://onlinelibrary.wiley.com/doi/10.1111/add.15681
9/14/2021

The Paper Authoring Tool (PAT) with Robert West

Ep. 33
Rob Calder talks to Professor Robert West about the Paper Authoring Tool (PAT). Professor West talks about how PAT can be used in the design and write-up phases of a randomised controlled trials, about how it saves time for reviewers and journals and about how using the PAT can make your research more rigorous, well reported and discoverable. He also discusses the future of research publishing and how computer reading can save months or years on evidence synthesis and how this relates to the Human Behaviour Change Project. There is also a small section on the interaction between computers, humans and chess.West, R. PAT: an on‐line paper authoring tool for writing up randomized controlled trials. Addiction 2021; 116: 1938-1940paperauthoringtool.com
7/15/2021

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Ep. 32
Jack Wilson talks to Rob Calder about his recent systematic review and meta-analysis on whether cannabis use increases the likelihood of later life opioid use or opioid use disorders. Jack talks about the limitations of the literature, the influence that the gateway hypothesis has had on policy and on some of the different types of studies that explore this issue. Wilson J, Mills K, Freeman TP, Sunderland M, Visontay R, and Marel C. Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction 2021; doi:10.1111/add.15581https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15581
6/14/2021

Cannabis, schizophrenia and genetics with Emma Johnson

Ep. 31
Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation. (Be sure to check out episode 22 too!)Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 https://doi.org/10.1111/add.15534
6/1/2021

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Ep. 30
Rob Calder talks to Dr Thomas Mason about his research on pay for performance models of addiction treatment and how they were associated with increased emergency hospital admissions. Mason T, Whittaker W, Jones A, Sutton M. Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference-in-differences analysis of a pay-for-performance scheme in England. Addiction 2021 https://doi.org/10.1111/add.15486
Copyright Suzi Gage
Hosted with ❤ by Acast